Medicinal reverse osmosis water purification device
The filtration system and reflux assembly combining activated carbon plates and reverse osmosis membranes solve the problem of impurity residue in existing technologies, achieving efficient removal of impurities and odors from water and ensuring the purity and safety of medicinal water.
Patent Information
- Application Number
- CN202520269710.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-19
- Publication Date
- 2025-12-02
- Estimated Expiration
- 2035-02-19
AI Technical Summary
Existing reverse osmosis pure water systems may leave impurities in the water during the treatment process, affecting the taste and odor of the water and causing it to fail to meet quality standards. This is especially problematic in the pharmaceutical industry, where it may harm the quality of medicines.
The filtration system uses a combination of activated carbon plates and reverse osmosis membranes, combined with a reflux assembly for multiple treatments to ensure that the water quality meets the standards. The activated carbon plates adsorb organic matter and odor substances, while the reverse osmosis membrane removes impurities such as dissolved salts, colloids, and bacteria under high pressure. The reflux assembly is used to regulate the system pressure and flow rate.
It effectively removes impurities and odors from water, improves water quality, ensures the purity and safety of medicinal water, avoids the addition of chemical substances, and achieves multiple treatments to ensure that the water quality meets standards.
Smart Images

Figure CN223620266U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of pharmaceutical reverse osmosis pure water technology, and more specifically to a pharmaceutical reverse osmosis pure water device. Background Technology
[0002] Pharmaceutical reverse osmosis pure water system is a water treatment equipment used in the pharmaceutical industry. It is mainly used to process raw water into high-purity pure water to meet the strict water quality requirements in the pharmaceutical process.
[0003] Existing reverse osmosis pure water systems may leave impurities in the water during the treatment process, resulting in poor taste and odor, affecting the quality of drinking water, reducing water purity, and even potentially posing health risks. This is especially true in fields with extremely high water quality requirements, such as pharmaceuticals, where it may lead to substandard drug quality, and water that has only undergone one filtration may still fail to meet the required standards.
[0004] Therefore, in order to solve the above problems, this application provides a pharmaceutical reverse osmosis pure water device. Utility Model Content
[0005] In order to overcome the above-mentioned defects of the prior art, the present invention provides a pharmaceutical reverse osmosis pure water device to solve the problems existing in the background art.
[0006] This utility model provides the following technical solution: a pharmaceutical reverse osmosis pure water device, comprising a main body, a raw water storage component, a treatment component, a drainage component, and a return component, wherein the raw water storage component is installed above the main body, the treatment component is installed above the main body, the drainage component is installed above the main body, and the return component is installed inside the drainage component.
[0007] Preferably, the main body includes a fixing plate, a base, and a signal controller, wherein the base is matrix-distributed and fixedly installed on the bottom of the fixing plate, and the signal controller is fixedly installed on the front wall of the fixing plate.
[0008] Preferably, the raw water temporary storage component includes a raw water storage tank, an inlet pipe, a first booster pump, a first delivery pipe, a U-shaped limiting plate, a first regulating valve, and a fixing block. The raw water storage tank is fixedly mounted on the fixing plate. The inlet pipe is fixedly inserted through the side wall of the raw water storage tank. The first booster pump is fixedly mounted above the raw water storage tank, and its output end is fixedly inserted through the top of the raw water storage tank. One end of the first delivery pipe is fixedly inserted through the rear wall of the raw water storage tank, and the other end is fixedly inserted through the rear wall of the treatment component. The U-shaped limiting plates are matrix-distributed and fixedly mounted on the rear wall of the fixing plate. The first regulating valve is fixedly mounted on the outer wall of the first delivery pipe. The first delivery pipe is fixedly inserted through the fixing block. The raw water temporary storage component facilitates the pressurization of water into the treatment component for processing.
[0009] Preferably, the treatment assembly includes a water treatment tank, a second booster pump, a pressure monitor, a filter plate, an activated carbon plate, a reverse osmosis membrane, a second water supply pipe, and a second regulating valve. The water treatment tank is fixedly mounted on a fixed plate, the second booster pump is fixedly mounted above the water treatment tank, and the output end of the second booster pump is fixedly installed through the top of the water treatment tank. The pressure monitor is fixedly mounted on the inner wall of the water treatment tank. The filter plate, activated carbon plate, and reverse osmosis membrane are movably fitted onto the inner wall of the water treatment tank. One end of the second water supply pipe is fixedly installed through the rear wall of the water treatment tank, and the other end of the second water supply pipe is fixedly installed through the rear wall of the drainage assembly. The second regulating valve is fixedly installed above the second water supply pipe. This treatment assembly facilitates improved efficiency in the raw water treatment process through pressurization.
[0010] Preferably, the drainage assembly includes a pure water storage tank, a drain pipe, a flow rate control valve, and a first side fixing block, wherein the pure water storage tank is installed above the fixing plate, the drain pipe is fixedly inserted through the first side fixing block and the side wall of the pure water storage tank, the flow rate control valve is fixedly installed above the drain pipe, and the first side fixing blocks are symmetrically distributed and fixedly installed on the side wall of the fixing plate.
[0011] Preferably, the reflux assembly includes a water quality detector, a reflux pipe, a second side fixing block, and a water pump. The water quality detector is fixedly installed inside the pure water storage tank. One end of the reflux pipe is fixedly inserted through the rear wall of the pure water storage tank, and the other end of the reflux pipe is fixedly inserted through the rear wall of the water treatment tank. The second side fixing block is fixedly installed on the rear wall of the fixing plate, and the water pump is fixedly installed above the second side fixing block. The output end of the water pump is fixedly connected to the reflux pipe. The reflux assembly facilitates real-time detection of whether the treated water meets the sample requirements. If it does not meet the standards, secondary treatment is performed.
[0012] The technical effects and advantages of this utility model are as follows:
[0013] 1. This utility model, by incorporating an activated carbon plate and a reverse osmosis membrane, facilitates the adsorption of organic matter and odor substances in the water by the activated carbon plate, thereby improving the taste and odor of the water. When the water passes through the reverse osmosis membrane, dissolved salts, colloids, bacteria, viruses and other impurities in the water are removed under high pressure, and no chemical substances need to be added in this process.
[0014] 2. By incorporating a reflux assembly, this utility model facilitates the return of a portion of the permeate or concentrate to the raw water tank or pretreatment system, effectively regulating the system's operating pressure and flow rate, and preventing damage to the membrane elements caused by excessively high or low pressure. Attached Figure Description
[0015] Figure 1 This is a front view schematic diagram of the overall structure of this utility model.
[0016] Figure 2 This is a schematic diagram of the overall rear view structure of this utility model.
[0017] Figure 3 This is a schematic diagram of the overall structure and some cross-sectional views of the present invention.
[0018] Figure 4 For the present utility model Figure 2 Schematic diagram of structure A in the middle.
[0019] The attached diagram is labeled as follows: 1. Main body; 101. Fixing plate; 102. Base; 103. Signal controller; 2. Raw water temporary storage assembly; 201. Raw water storage tank; 202. Inlet pipe; 203. First booster pump; 204. First water delivery pipe; 205. U-shaped limit plate; 206. First regulating valve; 207. Fixing block; 3. Processing assembly; 301. Water treatment tank; 302. Second booster pump; 303. Pressure monitor; 304, filter plate; 305, activated carbon plate; 306, reverse osmosis membrane; 307, second water supply pipe; 308, second regulating valve; 4, drainage assembly; 401, pure water storage tank; 402, drain pipe; 403, flow rate control valve; 404, first side fixing block; 5, reflux assembly; 501, water quality detector; 502, reflux pipe; 503, second side fixing block; 504, water pump. Detailed Implementation
[0020] The technical solution of this utility model will be clearly and completely described below with reference to the accompanying drawings. In addition, the forms of the various structures described in the following embodiments are merely illustrative. The pharmaceutical reverse osmosis pure water involved in this utility model is not limited to the structures described in the following embodiments. All other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this utility model.
[0021] Reference Figure 1-4 This utility model provides a pharmaceutical reverse osmosis pure water device, including a main body 1, a raw water storage component 2, a treatment component 3, a drainage component 4, and a return component 5. The raw water storage component 2 is installed above the main body 1, the treatment component 3 is installed above the main body 1, the drainage component 4 is installed above the main body 1, and the return component 5 is installed inside the drainage component 4.
[0022] The main body 1 includes a fixing plate 101, a base 102 and a signal controller 103, wherein the base 102 is matrix-distributed and fixedly installed on the bottom of the fixing plate 101, and the signal controller 103 is fixedly installed on the front wall of the fixing plate 101.
[0023] The raw water temporary storage assembly 2 includes a raw water storage tank 201, an inlet pipe 202, a first booster pump 203, a first water delivery pipe 204, a U-shaped limiting plate 205, a first regulating valve 206, and a fixing block 207. The raw water storage tank 201 is fixedly mounted on the fixing plate 101. The inlet pipe 202 is fixedly installed through the side wall of the raw water storage tank 201. The first booster pump 203 is fixedly installed above the raw water storage tank 201, and its output end is fixedly installed through the top of the raw water storage tank 201. One end of the first water supply pipe 204 is fixedly inserted through the rear wall of the raw water storage tank 201, and the other end of the first water supply pipe 204 is fixedly inserted through the rear wall of the treatment component 3. The U-shaped limiting plates 205 are distributed in a matrix and fixedly installed on the rear wall of the fixing plate 101. The first regulating valve 206 is fixedly installed on the outer wall of the first water supply pipe 204. The first water supply pipe 204 is fixedly inserted through the fixing block 207. The raw water temporary storage component 2 is provided, which is conducive to pressurizing the water and allowing it to enter the treatment component 3 for treatment.
[0024] The treatment component 3 includes a water treatment tank 301, a second booster pump 302, a pressure monitor 303, a filter plate 304, an activated carbon plate 305, a reverse osmosis membrane 306, a second water supply pipe 307, and a second regulating valve 308. The water treatment tank 301 is fixedly mounted on a fixed plate 101. The second booster pump 302 is fixedly mounted above the water treatment tank 301, with its output end fixedly penetrating the top of the water treatment tank 301. The pressure monitor 303 is fixedly mounted on the inner wall of the water treatment tank 301. The filter plate 304, activated carbon plate 305, and reverse osmosis membrane 306 are movably fitted onto the inner wall of the water treatment tank 301. One end of the second water supply pipe 307 is fixedly penetrating the rear wall of the water treatment tank 301, and the other end of the second water supply pipe 307 is fixedly penetrating the rear wall of the drainage component 4. The second regulating valve 308 is fixedly mounted above the second water supply pipe 307. The treatment component 3 is designed to improve the efficiency of raw water treatment through pressurization.
[0025] The drainage assembly 4 includes a pure water storage tank 401, a drain pipe 402, a flow rate control valve 403, and a first side fixing block 404. The pure water storage tank 401 is installed above the fixing plate 101. The drain pipe 402 is fixedly installed through the first side fixing block 404 and the side wall of the pure water storage tank 401. The flow rate control valve 403 is fixedly installed above the drain pipe 402. The first side fixing blocks 404 are symmetrically distributed and fixedly installed on the side wall of the fixing plate 101.
[0026] The reflux assembly 5 includes a water quality detector 501, a reflux pipe 502, a second side fixing block 503, and a water pump 504. The water quality detector 501 is fixedly installed inside the pure water storage tank 401. One end of the reflux pipe 502 is fixedly installed through the rear wall of the pure water storage tank 401, and the other end of the reflux pipe 502 is fixedly installed through the rear wall of the water treatment tank 301. The second side fixing block 503 is fixedly installed on the rear wall of the fixing plate 101. The water pump 504 is fixedly installed above the second side fixing block 503. The output end of the water pump 504 is fixedly connected to the reflux pipe 502. The reflux assembly 5 is provided to facilitate real-time detection of whether the treated water meets the sample. If it does not meet the standard, secondary treatment is performed.
[0027] The working principle of this utility model:
[0028] The device is placed horizontally above the ground. At this time, the operator sends raw water into the raw water storage tank 201 through the inlet pipe 202. The first booster pump 203 then starts working to increase the pressure inside the raw water storage tank 201, causing the raw water to enter the water treatment tank 301 through the first water delivery pipe 204. Simultaneously, the second booster pump 302 starts working to increase the pressure inside the water treatment tank 301. After entering the water treatment tank 301, the water passes through the filter plate 304 to remove impurities. Passing through the activated carbon plate 305, it adsorbs organic matter and odor substances in the water, thereby improving the taste and odor. When the water passes through the reverse osmosis membrane 306, dissolved salts, colloids, bacteria, viruses, and other impurities are removed under high pressure, and this process does not... No chemical substances need to be added. At this time, the treated water enters the pure water storage tank 401 through the second water supply pipe 307. At this time, the water quality detector 501 detects the treated water. If the detected water does not meet the predetermined standard value, this signal is defined as a non-compliance signal and sent to the signal controller 103. The signal controller 103 receives the non-compliance signal and controls the water pump 504 to start working. The output end of the water pump 504 pumps the water in the pure water storage tank 401 into the water treatment tank 301 through the return pipe 502 for secondary treatment. During the operation of the device, the fixed block 207 and the second regulating valve 308 can effectively control the flow rate of the water in the device, so that the entire device can achieve the function of reverse osmosis pure water.
[0029] Finally, the following points should be noted: First, in the description of this application, it should be noted that, unless otherwise specified and limited, the terms "installation", "connection", and "linkage" should be interpreted broadly, and can be mechanical or electrical connections, or internal connections between two components, or direct connections. "Up", "down", "left", "right", etc. are only used to indicate relative positional relationships. When the absolute position of the described object changes, the relative positional relationship may change.
[0030] Secondly: The accompanying drawings of the embodiments disclosed in this utility model only involve the structures involved in the embodiments disclosed in this utility model. Other structures can refer to the general design. In the absence of conflict, the same embodiment and different embodiments of this utility model can be combined with each other.
[0031] Finally: The above description is only a preferred embodiment of the present utility model and is not intended to limit the present utility model. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present utility model should be included within the protection scope of the present utility model.
Claims
1. A pharmaceutical reverse osmosis pure water device, comprising a main body (1), a raw water storage component (2), a treatment component (3), a drainage component (4), and a reflux component (5), characterized in that: The raw water storage component (2) is installed above the main body (1), the treatment component (3) is installed above the main body (1), the drainage component (4) is installed above the main body (1), and the return component (5) is installed inside the drainage component (4). The treatment component (3) includes a water treatment tank (301), a second booster pump (302), a pressure monitor (303), a filter plate (304), an activated carbon plate (305), a reverse osmosis membrane (306), a second water supply pipe (307), and a second regulating valve (308). The water treatment tank (301) is fixedly installed on the fixing plate (101), and the second booster pump (302) is fixedly installed on the fixing plate (101). The second booster pump (302) is fixedly installed above the water treatment tank (301). The output end of the second booster pump (302) is fixedly installed through the top of the water treatment tank (301). The pressure monitor (303) is fixedly installed on the inner wall of the water treatment tank (301). The filter plate (304), activated carbon plate (305), and reverse osmosis membrane (306) are movably sleeved on the inner wall of the water treatment tank (301). One end of the second water supply pipe (307) is fixedly installed through the rear wall of the water treatment tank (301). The other end of the second water supply pipe (307) is fixedly installed through the rear wall of the drainage assembly (4). The second regulating valve (308) is fixedly installed above the second water supply pipe (307).
2. The pharmaceutical reverse osmosis pure water device according to claim 1, characterized in that: The main body (1) includes a fixing plate (101), a base (102) and a signal controller (103), wherein the base (102) is matrix-distributed and fixedly installed on the bottom of the fixing plate (101), and the signal controller (103) is fixedly installed on the front wall of the fixing plate (101).
3. The pharmaceutical reverse osmosis pure water device according to claim 1, characterized in that: The raw water temporary storage assembly (2) includes a raw water storage tank (201), an inlet pipe (202), a first booster pump (203), a first water delivery pipe (204), a U-shaped limiting plate (205), a first regulating valve (206), and a fixing block (207). The raw water storage tank (201) is fixedly mounted on a fixing plate (101). The inlet pipe (202) is fixedly inserted through the side wall of the raw water storage tank (201). The first booster pump (203) is fixedly mounted above the raw water storage tank (201). The output end of the first water pipe (203) is fixedly inserted through the top of the raw water storage tank (201). One end of the first water pipe (204) is fixedly inserted through the rear wall of the raw water storage tank (201). The other end of the first water pipe (204) is fixedly inserted through the rear wall of the processing component (3). The U-shaped limiting plates (205) are matrix-distributed and fixedly installed on the rear wall of the fixing plate (101). The first regulating valve (206) is fixedly installed on the outer wall of the first water pipe (204). The first water pipe (204) is fixedly inserted through the fixing block (207).
4. The pharmaceutical reverse osmosis pure water device according to claim 1, characterized in that: The drainage assembly (4) includes a pure water storage tank (401), a drain pipe (402), a flow rate control valve (403), and a first side fixing block (404). The pure water storage tank (401) is installed above the fixing plate (101). The drain pipe (402) is fixedly inserted through the first side fixing block (404) and the side wall of the pure water storage tank (401). The flow rate control valve (403) is fixedly installed above the drain pipe (402). The first side fixing blocks (404) are symmetrically distributed and fixedly installed on the side wall of the fixing plate (101).
5. A pharmaceutical reverse osmosis pure water device according to claim 1, characterized in that: The reflux assembly (5) includes a water quality detector (501), a reflux pipe (502), a second side fixing block (503), and a water pump (504). The water quality detector (501) is fixedly installed inside the pure water storage tank (401). One end of the reflux pipe (502) is fixedly installed through the rear wall of the pure water storage tank (401), and the other end of the reflux pipe (502) is fixedly installed through the rear wall of the water treatment tank (301). The second side fixing block (503) is fixedly installed on the rear wall of the fixing plate (101). The water pump (504) is fixedly installed above the second side fixing block (503), and the output end of the water pump (504) is fixedly connected to the reflux pipe (502).